TSC BioVenture Capital

TSC BioVenture Capital is a Taiwan-based venture capital firm specializing in early to late-stage investments within the life sciences and healthcare sectors. Founded in 2002 and headquartered in Taipei, the firm targets companies with proprietary technologies that have the potential to achieve substantial returns in large, unmet medical markets. Its investment portfolio includes several prominent Taiwanese biotechnology and pharmaceutical companies, such as TaiMed Biologics, SynCore Biotechnology, and Bora Pharmaceuticals. The firm plays a strategic role in the development of the Taiwanese biotech ecosystem, often co-investing with global venture capital funds to support innovative therapeutic and diagnostic solutions. TSC BioVenture Capital is led by experienced industry professionals with deep ties to the regional medical and pharmaceutical communities.